Entries tagged "APP Pharmaceuticals"
This week's episode of The Deal Calendar goes back to school. The Deal's Mary Kathleen Flynn speaks with The Deal's senior writer Matt Miller about the student loan crisis. The layers of lending have led to consolidation in the sector. ...
Monday began with a rush of deal activity, pushing the markets slightly into the green. German pharmaceutical company Fresenius SE agreed to pay up to $5.6 billion including debt for APP Pharmaceuticals Inc., while General Electrical Co. through a subsidiary added the Weather Channel. Meanwhile, all forecasts show that Merrill Lynch & Co. is moving closer to selling its stake in financial publisher Bloomberg LP and is weighing the sale of its stake in BlackRock Inc. Behind all this activity, the Dow went on a roller-coaster ride, gaining in the morning but giving up 110.23, or 0.89%, by the early...
Healthcare group Fresenius SE finally secured a U.S. foothold for its intravenous drugs business with an agreed offer for APP Pharmaceuticals Inc. worth as much as $5.6 billion in cash and debt. ...
